fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

New Test of “Smart Bomb” Drug: A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer

GCF board member Dr. James Ford will be managing the Northern California trial site for a major international study in gastric cancer of a new drug from Roche’s Genentech unit.

Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X